Katarzyna Lisowska, leader of the Hematooncology Association, sums up 2022

– A lot has happened in hematooncology in 2022. Patients have received a lot of therapy. In haemato-oncological diseases, only drugs are considered and for us this is the basis. We got a lot of medicines in the reimbursement system, for which we were waiting - said Katarzyna Lisowska, the leader of the Hematooncology Association, in an interview with Medexpress, summing up the ending year.